Sipai Health Technology Co (HKSE:00314) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00314 Sipai Health Technology Co Ltd HKSE:00314
64 GF Score
Price HK$1.50
GF Value HK$2.39
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Sipai Health Technology Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Sipai Health Technology Co Valuation Rank Related Terms

HKSE:00314
64GF Score
Sipai Health Technology Co Ltd HKSE:00314
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sipai Health Technology Co (HKSE:00314) Overvalued in 2026?

Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued. The current stock price of HK$1.50 is trading 37.4% below its estimated GF Value™ of HK$2.39. GuruFocus considers Sipai Health Technology Co to be Possible Value Trap.

Key valuation signals for HKSE:00314:

  • Valuation Rank:
  • GF Value™: HK$2.39 vs. price of HK$1.50 (37.4% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the HKSE:00314 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sipai Health Technology Co Business Description

Other Exchanges AX1:Germany
Address 128 Tianmu West Road, 1603-1605A, 16th Floor, Tower 1, Kerry Enterprise Center, Jing\'an District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
64GF Score

Get the complete analysis for HKSE:00314

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.50
Price
HK$2.39
GF Value